Last reviewed · How we verify

NCT06333184

Smoothies and Blood Sugars

Completed NA Last updated 19 September 2024
What this trial tests

NA trial testing Food in Metabolic Disturbance in 15 participants. Completed in 30 August 2024.

Timeline
20 March 2024
Primary endpoint
30 August 2024
30 August 2024

Quick facts

Lead sponsorUniversity of Bath
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposebasic science
Enrollment15
Start date20 March 2024
Primary completion30 August 2024
Estimated completion30 August 2024
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

University of Bath

Who can join

Adults 18 to 65, any sex, with Metabolic Disturbance. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Glycaemic responses to fruit smoothies may depend on the food matrix (e.g., degree of processing and physical structure), ingestion rate, dose ingested and fibre content. Furthermore, the method of sampling could alter inferences. The aim of this project is to characterise how these factors affect the glycaemic response to a commercially available fruit smoothie. Participants will ingest 7 different test drinks in a randomised, crossover design with fingerstick capillary blood sampling alongside continuous glucose monitors. Test drinks will include a glucose reference (CONTROL), the commercial product matched for carbohydrate to CONTROL (PRODUCT), equivalent carbohydrate ingested as whole fruits (WHOLE), equivalent carbohydrate ingested as blended fruits (WHOLE), equivalent carbohydrate as the commercial product ingested slowly (SLOW), equivalent carbohydrate as the commercial product ingested with additional fibre (FIBRE), and the commercial product ingested in a dose typically bought (DOSE). These data will provide insight into how the food matrix and different patterns of ingestion can alter the glycaemic response to a fruit smoothie, and how the measurement method may alter interpretations.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Continuous glucose monitor overestimates glycemia, with the magnitude of bias varying by postprandial test and individual - a randomized crossover trial.
    Hutchins KM, Betts JA, Thompson D, Hengist A, et al · · 2025 · cited 9× · PMID 40021059 · DOI 10.1016/j.ajcnut.2025.02.024

Verify or expand the search:

Other trials of Food

Trials testing the same drug.

Other recruiting trials for Metabolic Disturbance

Currently open trials in the same condition.

Other University of Bath trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06333184.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing